KOL Selection in Co-Commercialization | Acceleration Point | Resources

Key Takeaways

Co-commercialization partners often begin with different views of which KOLs matter most, so a shared definition of selection parameters is the first step toward alignment.
A data-driven approach, drawing on clinical trial involvement, publication record, speaking engagements, and digital influence, supports a more objective KOL candidate list.
KOL segmentation assigns each KOL to a category such as data generators, data disseminators, educators, or digital influencers, rather than simply marking someone as a KOL or not.
Segmentation supports balanced territory design and clarifies which partner team is best suited to lead each KOL relationship.
A shared KOL planning tool gives partner organizations a single space to coordinate and maintain visibility of engagement activity.
Peer-reviewed evidence indicates opinion leaders can help promote evidence-based practice, which is one reason accurate, criteria-based identification is worth the effort.

In a co-commercialization agreement, two or more organizations promote the same product or therapy together, and each brings its own view of which Key Opinion Leaders (KOLs) matter most. KOL selection and prioritization is the process of identifying which KOLs are most relevant to a product or therapy area and ranking them so engagement effort matches scientific relevance. In a co-commercialization setting, that process is rarely straightforward, because partner organizations often hold different perspectives and strategies. This article sets out a data-driven approach to more objective and efficient KOL selection and prioritization, along with the segmentation and planning steps that keep partner teams aligned.

For a closer look at the specific obstacles partners face, see our companion article on the key challenges and effective solutions in KOL engagement for co-commercialization agreements.

Why Do Co-Commercialization Partners Disagree on Which KOLs Matter?

In a co-commercialization scenario, each participating organization brings its own view of which KOLs are most influential and relevant to the product or therapy area. That difference in perception is often the first obstacle: agreeing on a common list of KOLs that meets the strategic goals of every partner.

How Do Selection Parameters and Data Make KOL Selection More Objective?

The first step is a clear definition of selection parameters, so every partner shares the same understanding of what makes a KOL relevant to the product or therapy. With parameters agreed, a data-driven approach supports a more objective identification of candidates. Examining factors such as clinical trial involvement, publication record, speaking engagements, and digital influence produces a candidate list the team can review. For a fuller view of how teams structure this work, see our guide to the components of a successful KOL engagement strategy.

A 2019 Cochrane systematic review analyzed 24 studies involving more than 300 hospitals and over 29,000 patients and found that local opinion leaders, alone or combined with other approaches, probably improve healthcare professionals' compliance with evidence-based practice (Flodgren et al., Cochrane Database of Systematic Reviews). That evidence base is one reason accurate, criteria-based identification of opinion leaders is worth the effort.

What Is KOL Segmentation, and Why Does It Matter?

Identifying KOLs is only the start. KOL segmentation assigns each KOL to a category that aligns with the strategic goals of the partnership, rather than simply marking someone as a KOL or not. Common segments include data generators (based on clinical trial activity), data disseminators (linked to publication and congress activity), educators (based on speaking engagements), and digital influencers (based on the reach of their online content). Segmentation supports more tailored engagement and helps identify which team is best suited to lead with each KOL. For a modern treatment of how teams define these categories, see our article on rethinking thought leader segmentation, and for the digital-influencer segment specifically, our overview of digital ways to engage key opinion leaders.

How Does Segmentation Support Territory Design?

Segmentation also supports effective territory design, with balanced responsibilities and fewer potential conflicts. A KOL who is primarily a data generator may sit with a team involved in clinical trials, while a digital influencer may be best managed by a team skilled in digital communication. To keep coordination consistent, partners can integrate KOL segmentation into a shared KOL planning tool, such as Kwello, giving teams across organizations a single space to coordinate and maintain visibility of KOL engagement activity.

Conclusion

Selecting and prioritizing KOLs in co-commercialization agreements is a complex task, but a data-driven approach, clear segmentation, and shared planning tools give Medical Affairs teams a practical way to align. Together, these steps support effective, well-matched KOL engagement that reflects the shared goals of the partnership.

Have questions? Reach out to our team.

Frequently Asked Questions

What is KOL selection and prioritization in a co-commercialization agreement?
KOL selection and prioritization is the process of identifying which Key Opinion Leaders are most relevant to a product or therapy area and ranking them so engagement effort matches their scientific relevance. In a co-commercialization agreement, partner organizations do this together so they can align on a shared set of priority KOLs.

Why do co-commercialization partners disagree on which KOLs to prioritize?
Each partner organization brings its own view of which KOLs are most influential and relevant to the product or therapy area. Those differing perspectives make it hard to agree on a common list, which is why a shared definition of selection parameters is the recommended starting point.

What is KOL segmentation, and what categories are commonly used?
KOL segmentation assigns each KOL to a category that aligns with the partnership's goals, rather than treating all KOLs the same. Common segments include data generators (clinical trial activity), data disseminators (publication and congress activity), educators (speaking engagements), and digital influencers (reach of online content).

How does KOL segmentation support territory design?
Segmentation clarifies which team is best suited to lead each KOL relationship, which supports balanced territory design and fewer conflicts. For example, a data generator may sit with a clinical trials team, while a digital influencer may be managed by a team skilled in digital communication.

What role does a KOL planning tool play in co-commercialization?
A shared KOL planning tool gives partner teams across different organizations a single space to coordinate engagement and maintain visibility of KOL activity. Kwello is an example of a collaborative KOL planning tool used for this purpose.

KOL Selection and Prioritization in Co-Commercialization Agreements